A digital lifestyle program was linked to lasting improvements in several measures reported by multiple sclerosis patients, a study says.

New research and input from people living with MS are changing how the disease is diagnosed and treated — a shift that will ...

To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently ...

A narrative review finds specialty pharmacies lack a patient-reported outcome measure built for their workflow, despite ...

WEST PALM BEACH, Fla. — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, highlighting the ...

Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, causing episodes of neurologic dysfunction and often gradual disease progression. The immune system ...

Roche (RHHBY) unit Genentech on Wednesday announced that the FDA has granted priority review to a marketing application for fenebrutinib, designed as an oral treatment for a central nervous system ...

Multiple Sclerosis (MS) imposes a significant psychological burden that adversely affects patients’ subjective well-being (SWB). A primary psychological stressor in this population is the Fear of ...

Registry-linked gross income trajectories (wages, capital gains, transfers) showed lower long-term income growth in 1,071 MS cases versus 15,493 matched controls, with 72% women in the cohort.

A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ...

A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of ...